10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of May 21, 2026, TXG trades at $23.64 with a market cap of $2.72B and a P/E ratio of -137.82. TXG moved +7.58% today. Year to date, TXG is +30.90%; over the trailing twelve months it is +164.10%. Its 52-week range spans $6.78 to $26.45. Analyst consensus is buy with an average price target of $24.10. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for TXG combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $23.64 |
| Market Cap | $2.72B |
| P/E Ratio | -137.82 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.45 |
| 52-Week Low | $6.78 |
| Volume | 32 |
| Avg Volume | 0 |
| Revenue (TTM) | $638.78M |
| Net Income | $-22.66M |
| Gross Margin | 69.60% |
12 analysts cover TXG: 0 strong buy, 4 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $24.10.